Compositions and methods for treatment of subjects suffering from a sars-cov-2 infection
AssigneesRenovion, Inc., The UAB Research Foundation
InventorsCarolyn DURHAM, Dan COPELAND, Steven M. ROWE, Javier CAMPOS-GOMEZ
Life of this patent
Estimating the term…
Abstract
The application is directed to methods for treatment or prevention of SARS-CoV-2 infection in a subject in need thereof, the composition comprising an organic acid (e.g., ascorbic acid), glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically acceptable salt thereof, and methods of using the same.
Claims28
A method of treating, preventing, or reducing the risk of an infection by SARS-CoV-2 in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition comprising:
- (a) glutathione, a glutathione derivative, a glutathione conjugate, or a pharmaceutically acceptable salt of glutathione, a glutathione derivative, or a glutathione conjugate;
- and
- (b) an organic acid or a pharmaceutically acceptable salt thereof.
A method of reducing one or more symptoms or signs of an infection by SARS-CoV-2, comprising administering to the subject a therapeutically effective amount of a composition comprising:
- (a) glutathione, a glutathione derivative, a glutathione conjugate, or a pharmaceutically acceptable salt of glutathione, a glutathione derivative, or a glutathione conjugate;
- and
- (b) an organic acid or a pharmaceutically acceptable salt thereof.
A method of protecting the lungs of a subject suffering from SARS-CoV-2 from cilia damage comprising administering to the airway of the subject a composition comprising:
- (a) glutathione, a glutathione derivative, a glutathione conjugate, or a pharmaceutically acceptable salt of glutathione, a glutathione derivative, or a glutathione conjugate;
- and (b) an organic acid or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.